CN Home RSS Feed - MedPage Today

Metabolism, Genetics May Impact Tumor Biology in Breast Cancer Populations

Govindarajan Narayanan, MD, speaks to the potential time-saving advantages of using the Epione robot for microwave ablation, cryoablation, and other surgical strategies in patients with liver cancer and other tumors.

Latin American patients appear more likely to be diagnosed with aggressive early-stage breast cancer based on factors including metabolics and genetics, according to findings from the FLEX study.

Tanios S. Bekaii-Saab, MD, Speaks to Expanding Horizons in CRC Treatment

Latin American patients appear more likely to be diagnosed with aggressive early-stage breast cancer based on factors including metabolics and genetics, according to findings from the FLEX study.

Personalized therapy tailored for mutation status is something to expect in the coming years for colorectal cancer treatment, notes Tanios S. Bekaii-Saab, MD.

November 27th 2023

T-DM1 Improves OS/iDFS Vs Trastuzumab in HER2+ Breast Cancer

Personalized therapy tailored for mutation status is something to expect in the coming years for colorectal cancer treatment, notes Tanios S. Bekaii-Saab, MD.

Investigators observe no new safety signals with trastuzumab emtansine as a treatment for HER2-positive breast cancer after 8 years of follow-up in the phase 3 KATHERINE study.

FDA Approves Isavuconazonium Sulfate for Pediatric Fungal Infections

Investigators observe no new safety signals with trastuzumab emtansine as a treatment for HER2-positive breast cancer after 8 years of follow-up in the phase 3 KATHERINE study.

Patients who are under the age of 17 with invasive mucormycosis or invasive aspergillosis, which is an AE of leukemia, can now receive isavuconazonium sulfate following FDA approval

Atezolizumab Combo Numerically Improves pCR in HER2+ Operable Breast Cancer

Patients who are under the age of 17 with invasive mucormycosis or invasive aspergillosis, which is an AE of leukemia, can now receive isavuconazonium sulfate following FDA approval

Related Content

December 9th 2023

Adapting to a Robotic Workstation for Image-Guided Liver Cancer Surgery

Treatment with atezolizumab among patients with HER2-positive breast cancer in the phase 3 APTneo Michelangelo trial produces no major tolerability issues, says Luca Gianni, MD.

December 4th 2023

Metabolism, Genetics May Impact Tumor Biology in Breast Cancer Populations

Tanios S. Bekaii-Saab, MD, Speaks to Expanding Horizons in CRC Treatment

Latin American patients appear more likely to be diagnosed with aggressive early-stage breast cancer based on factors including metabolics and genetics, according to findings from the FLEX study.

November 27th 2023

T-DM1 Improves OS/iDFS Vs Trastuzumab in HER2+ Breast Cancer

Personalized therapy tailored for mutation status is something to expect in the coming years for colorectal cancer treatment, notes Tanios S. Bekaii-Saab, MD.

FDA Approves Isavuconazonium Sulfate for Pediatric Fungal Infections

Investigators observe no new safety signals with trastuzumab emtansine as a treatment for HER2-positive breast cancer after 8 years of follow-up in the phase 3 KATHERINE study.